Extended Data Fig. 6: Phenotypic evaluation of macrophage after CCM treatment.
From: Pharmacological targeting of BMAL1 modulates circadian and immune pathways
Principal component analysis of the wild-type samples suggest that CCM treatment can partially revert the gene expression profile of LPS-treated cells towards the baseline profile of vehicle-treated controls. CCM alone does not significantly alter the gene expression profile compared to the control.
